|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Lymphedema | |||||
| Musculoskeletal Complications | |||||
| Radiation Fibrosis | |||||
| Radiation Toxicity | |||||
| Sarcoma | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Fibrosis | |||||
| Radiation Pneumonitis | |||||
| 3 | More general conditions related to this trial | ||||
| Disorders of Environmental Origin | |||||
| Lung Diseases | |||||
| Lung Diseases, Interstitial | |||||
| Lymphatic Diseases | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Neoplasms, Connective and Soft Tissue | |||||
| Pathologic Processes | |||||
| Radiation Injuries | |||||
| Respiratory Tract Diseases | |||||
| Wounds and Injuries | |||||
| 4 | Interventions listed in this trial | ||||
| chemotherapy | |||||
| 5 | Sponsors listed in this trial | ||||
| Radiation Therapy Oncology Group | |||||
| National Cancer Institute (NCI) | |||||